After a year of absolute uncertainty, micro-predictions and near constant recalculations, the picture of our world and what’s next in it is becoming clearer.
If there’s one through line in this year’s report, it’s this: we are an industry working toward sustainable acceleration in the product management lifecycle. The disruption of the pandemic fueled fast-moving innovation, including untold experience cycles that showed leaders what was possible in a crisis.
- Discover the ten key trends shaping the biopharmaceutical industry in 2022 and beyond
- Explore the new clinical and commercial models that are emerging in a climate that is incredibly challenged
- Consider the implications for sponsors, healthcare practitioners, patients and other industry stakeholders